Pattern of cutaneous adverse drug reactions due to the use of fixed dose drug combinations
Keywords:
Adverse drug reaction, Drug combination, Inappropriate prescribing, PreventabilityAbstract
Background: Fixed dose drug combinations (FDCs) possess a higher risk of causing adverse drug reactions (ADRs) compared to a drug used individually. This study analyzes the pattern of ADRs caused due to the use of FDCs in a tertiary care hospital.
Methods: A prospective, spontaneous ADR reporting study was conducted for two years at a tertiary care hospital. ADRs reported due to suspected FDC use were evaluated for causality (WHO-UMC probability scale), severity (adapted Hartwig scale) and avoidability (Modified Hallas J. et al. scale).
Results: Of the 29 (96.67%) cutaneous ADRs reported, 19 (63.34%) ADRs were due to irrational FDCs, of which 16 (53.34%) were ‘probable’, 13 (43.34%) were ‘possibly avoidable’ and 13 (43.34%) were ‘mild/level 2’ on the severity scale.
Conclusion: Irrational FDCs carry a higher risk of causing cutaneous ADRs. Awareness and regular reporting of such ADRs can help physicians fight the evil of irrational prescribing.
Metrics
References
Palanisamy S, Kumaran KSGA, Rajasekaran A. A study on adverse drug reactions in Indian hospital. Imperial J Pharmacology & Toxicology 2011;1(1):7-15.
Shah SP, Desai MK, Dixit RK. Analysis of cutaneous adverse drug reactions at a tertiary care hospital – A prospective study. Tropical Journal of Pharmaceutical Research 2010;10(4):517-22.
Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospitals: A narrative review. Current Drug Safety 2007;2:79-87.
Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol 2007;65(3):396-406.
Ghosh S, Acharya LD, Rao PG. Study and evaluation of the various cutaneous adverse drug reactions in Kasturba Hospital, Manipal. Indian J Pharm Sci 2006;68(2):212-5.
Gautam CS, Saha L. Fixed dose drug combinations (FDCs): Rational or irrational: a view point. Br J Clin Pharmacol 2007;65(5):795-6.
Jadav SP, Parmar DM. Critical appraisal of irrational drug combinations: A call for awareness in undergraduate medical students. J Pharmacol Pharmacother 2011;2(1):45-8.
World Health Organization (WHO). The Importance on Pharmacovigilance. Safety monitoring on Medicinal Products. Geneva (Switzerland): Office of Publications, World Health Organization; 2002.
Davies EC, Green CF, Taylor, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLoS ONE. 2009; 4(2): e4439. doi: 10.1371/journal.pone.0004439.
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004;329(3):15-9.
World Health Organization (WHO). WHO model list of essential drugs. 17th list. March 2011. Available from: http://whqlibdoc.who.int/hq/2011/a95053_eng.pdf.
World Health Organization (WHO). National List of Essential Medicines, NLEM (2011). Available from: http://apps.who.int/medicinedocs/en/m/abstract/Js18693en/.
Aagaard L, Hansen EH. Information about ADRs explored by Pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clinical Pharmacology 2009;9(4):1-14.
Gautam CS, Aditya S. Irrational drug combinations: Need to sensitize undergraduates. Indian J Pharmacol 2006;38(3):169-70.
Palaian S, Ibrahim MIM, Mishra P. Pattern of adverse drug reactions reported by the community pharmacists in Nepal. Pharmacy Practice (Internet) 2010;8(3):201-7.
Sivanandy P, Kottur SGAK, Aiyalu R. A study on assessment, monitoring and reporting of adverse drug reactions in Indian hospital. Asian J Pharm Clin Res 2011;4(3):112-6.
Singh H, Dulhani N, Kumar BN, Singh P, Tewari P, Nayak K. A pharmacovigilance study in medicine department of tertiary care hospital in Chhattisgarh (Jagdalpur), India. J Young Pharm. 2010;2(1):95-100.
